Laddar...
Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
The combination of BRAF-targeted agents with immune checkpoint inhibitors represents a recent advance in the treatment of melanoma, even though each of these therapeutic approaches alone has specific limitations. Increasing evidence suggests indeed the existence of a synergistic interaction between...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Landes Bioscience
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3667913/ https://ncbi.nlm.nih.gov/pubmed/23762807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24320 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|